Loading...

Global Consumption And Sustainable Surfactants Will Drive Future Potential

Published
10 Mar 25
Updated
21 Aug 25
AnalystConsensusTarget's Fair Value
₹2,703.17
18.9% undervalued intrinsic discount
04 Sep
₹2,192.00
Loading
1Y
-28.0%
7D
-2.7%

Author's Valuation

₹2.7k18.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update21 Aug 25
Fair value Decreased 5.18%

The downward revision in Galaxy Surfactants’ price target is primarily driven by reduced revenue growth forecasts and a lower future P/E multiple, resulting in a new consensus fair value of ₹2703.


What's in the News


  • Upcoming board meeting to consider and approve unaudited financial results for the quarter ended June 30, 2025.
  • Held a capital market day in 2025.

Valuation Changes


Summary of Valuation Changes for Galaxy Surfactants

  • The Consensus Analyst Price Target has fallen from ₹2851 to ₹2703.
  • The Consensus Revenue Growth forecasts for Galaxy Surfactants has significantly fallen from 9.1% per annum to 8.1% per annum.
  • The Future P/E for Galaxy Surfactants has fallen from 35.45x to 32.22x.

Key Takeaways

  • Product innovation and focus on sustainable, specialty surfactants align with shifting consumer preferences and are expected to support premiumization and margin improvement.
  • Strategic partnerships, operational agility, and geographic diversification enhance revenue stability and protect profitability amid global supply chain risks.
  • Margin and growth headwinds stem from trade uncertainties, raw material inflation, geopolitical instability, strong global competition, and weak demand with customer destocking.

Catalysts

About Galaxy Surfactants
    Manufactures and sells surfactants and other specialty ingredients for the personal and home care industry in India and internationally.
What are the underlying business or industry changes driving this perspective?
  • Sustained demand growth is expected as rising incomes, urbanization, and increased health and hygiene awareness continue to boost global consumption of personal and home care products-the primary end markets for Galaxy Surfactants-supporting consistent long-term volume expansion and revenue growth.
  • Ongoing product innovation, as evidenced by the recent patented, eco-friendly, enzyme-based surfactant launch (Galaxy Hearth, Biosurf), positions the company to benefit from accelerating consumer preference and regulatory push for sustainable, biodegradable ingredients, creating potential for premiumization and net margin uplift.
  • The company is deepening strategic partnerships with global and regional FMCG players, aiming to reduce customer concentration risk and ensure a more predictable, recurring revenue base, which is expected to stabilize topline growth and support improved earnings visibility.
  • Management is actively investing in operational agility-including geographic diversification of supply, flexible manufacturing, and raw material risk management-enabling Galaxy Surfactants to better navigate supply chain disruptions and tariff risks, thereby protecting profitability and gross margins.
  • The company's long-term strategy (Vision 2030) emphasizes expansion into high-value specialty surfactants and innovation-driven segments, which should progressively enhance the overall product mix and drive EBITDA per ton higher over time, supporting sustained long-term earnings growth.

Galaxy Surfactants Earnings and Revenue Growth

Galaxy Surfactants Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Galaxy Surfactants's revenue will grow by 8.1% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 6.7% today to 7.5% in 3 years time.
  • Analysts expect earnings to reach ₹4.3 billion (and earnings per share of ₹121.16) by about September 2028, up from ₹3.0 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as ₹3.8 billion.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 32.2x on those 2028 earnings, up from 26.8x today. This future PE is greater than the current PE for the IN Chemicals industry at 26.8x.
  • Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 13.51%, as per the Simply Wall St company report.

Galaxy Surfactants Future Earnings Per Share Growth

Galaxy Surfactants Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Heightened tariff and trade uncertainties, especially regarding exports to North America, could lead to margin pressure (as the company may absorb some of the cost or face demand slowdown) and reduce both revenue and net profit growth if the situation persists or escalates.
  • Prolonged raw material (feedstock) price inflation without the ability to consistently pass on costs, or the risk of being left with high-priced inventory if prices suddenly correct, may compress gross and net margins, increasing earnings volatility.
  • The slow recovery and continued geopolitical instability in key regions like Egypt and Turkey within the AMET segment-combined with local backward-integrated competitors-represent a risk to regional revenue growth, asset utilization, and overall earnings stability.
  • Intensifying competition from established global specialty chemical leaders (e.g., BASF, Croda) in the US and Europe, especially given Galaxy's comparatively smaller size and product range, may limit market share gains, pricing power, and long-term revenue expansion in these high-margin geographies.
  • Persistently subdued demand and cautious customer inventory management (including destocking in anticipation of price corrections or uncertain end-market dynamics) could translate to slower volume growth, underutilization of capacity, and pressure on both top-line revenue and bottom-line profitability.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of ₹2703.167 for Galaxy Surfactants based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ₹3240.0, and the most bearish reporting a price target of just ₹2333.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be ₹57.2 billion, earnings will come to ₹4.3 billion, and it would be trading on a PE ratio of 32.2x, assuming you use a discount rate of 13.5%.
  • Given the current share price of ₹2307.2, the analyst price target of ₹2703.17 is 14.6% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives